Benchmark Upgrades Emergent BioSolutions (EBS) to Buy

January 20, 2022 6:21 AM EST Send to a Friend
Benchmark analyst Robert Wasserman upgraded Emergent BioSolutions (NYSE: EBS) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login